Principal Financial Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15M | Sell |
565,066
-33,069
| -6% | -$876K | 0.01% | 1028 |
|
|
2025
Q1 | $14.4M | Sell |
598,135
-30,629
| -5% | -$740K | 0.01% | 1046 |
|
|
2024
Q4 | $25.3M | Buy |
628,764
+35,236
| +6% | +$1.42M | 0.01% | 721 |
|
|
2024
Q3 | $37.6M | Buy |
593,528
+136,729
| +30% | +$8.66M | 0.02% | 563 |
|
|
2024
Q2 | $24.2M | Buy |
456,799
+95,960
| +27% | +$5.09M | 0.01% | 750 |
|
|
2024
Q1 | $29.6M | Buy |
360,839
+349,725
| +3,147% | +$28.7M | 0.02% | 687 |
|
|
2023
Q4 | $207K | Buy |
11,114
+971
| +10% | +$18.1K | ﹤0.01% | 2160 |
|
|
2023
Q3 | $112K | Sell |
10,143
-1,208
| -11% | -$13.4K | ﹤0.01% | 2265 |
|
|
2023
Q2 | $184K | Buy |
+11,351
| New | +$184K | ﹤0.01% | 2196 |
|
|
2021
Q4 | – | Sell |
-14,727
| Closed | -$92K | – | 2642 |
|
|
2021
Q3 | $92K | Sell |
14,727
-2,387
| -14% | -$14.9K | ﹤0.01% | 2510 |
|
|
2021
Q2 | $103K | Buy |
17,114
+946
| +6% | +$5.69K | ﹤0.01% | 2530 |
|
|
2021
Q1 | $102K | Buy |
16,168
+1,137
| +8% | +$7.17K | ﹤0.01% | 2422 |
|
|
2020
Q4 | $85K | Buy |
15,031
+329
| +2% | +$1.86K | ﹤0.01% | 2370 |
|
|
2020
Q3 | $86K | Sell |
14,702
-728
| -5% | -$4.26K | ﹤0.01% | 2277 |
|
|
2020
Q2 | $111K | Buy |
15,430
+4,889
| +46% | +$35.2K | ﹤0.01% | 2241 |
|
|
2020
Q1 | $49K | Hold |
10,541
| – | – | ﹤0.01% | 2155 |
|
|
2019
Q4 | $85K | Buy |
+10,541
| New | +$85K | ﹤0.01% | 2195 |
|